United Therapeutics director gets 1,310 shares

UNITED THERAPEUTICS Corp director Judy D. Olian reported the vesting of equity awards.

Rhea-AI Filing Summary

UNITED THERAPEUTICS Corp director Judy D. Olian reported the vesting of equity awards. On July 9, 2026, 1,310 Restricted Stock Units vested and converted on a one-for-one basis into 1,310 shares of common stock at an exercise price of $0.00 per share. Following this conversion, Olian holds 5,555 shares of common stock directly, and the reported Restricted Stock Unit position is reduced to zero. The transactions reflect compensation-related vesting, not an open‑market purchase or sale.

Filing Explained

The July 9 vesting completed conversion of 1,310 RSUs into common shares; the filer reported 5,555 directly held shares afterward.

The July 13 Form 4 reports that 1,310 restricted stock units vested on July 9, 2026 and converted one-for-one into 1,310 shares of United Therapeutics common stock.

The transaction is coded M, which the supplied Form 4 definition identifies as an option or derivative exercise, and the filing shows 5,555 common shares held directly afterward.

The derivative table shows the 1,310 restricted stock units converted into common stock and no remaining derivative securities from that reported transaction.

Insider Trade Summary

1,310 shares exercised/converted

Exercise 2 txns

Insider Olian Judy D.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1, F2	1,310	--	--
Exercise	Common Stock F1	1,310	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Common Stock — 5,555 shares (Direct)

Footnotes (2)

1. F1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.
2. F2. Not applicable as restricted stock units do not have an expiration date.

Key Figures

RSUs vested and converted: 1,310 units Exercise/Conversion price: $0.00 per share Shares held after transaction: 5,555 shares +1 more

4 metrics

RSUs vested and converted 1,310 units Restricted Stock Units vested and converted into common stock on July 9, 2026

Exercise/Conversion price $0.00 per share Conversion of Restricted Stock Units into common stock

Shares held after transaction 5,555 shares Common stock directly owned by Judy D. Olian after July 9, 2026 transactions

RSU balance after vesting 0 units Total Restricted Stock Units reported following the vesting and conversion

Key Terms

Restricted Stock Unit, vesting, one-for-one basis

3 terms

Restricted Stock Unit financial

"Shares received upon vesting of restricted stock units on July 9, 2026."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

vesting financial

"Shares received upon vesting of restricted stock units on July 9, 2026."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

one-for-one basis financial

"Restricted stock units converted on a one-for-one basis into shares of common stock."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did UNITED THERAPEUTICS (UTHR) director Judy D. Olian report?

Judy D. Olian reported vesting of 1,310 Restricted Stock Units on July 9, 2026, which converted into 1,310 shares of common stock. This was a compensation-related derivative exercise/conversion, not an open-market trade.

How many UNITED THERAPEUTICS (UTHR) shares does Judy D. Olian hold after this Form 4?

After the July 9, 2026 transactions, Judy D. Olian directly holds 5,555 shares of common stock. These holdings reflect shares received from the conversion of 1,310 Restricted Stock Units and any prior holdings reported.

Were UNITED THERAPEUTICS (UTHR) shares bought or sold on the market in this Form 4?

No open-market buys or sells occurred. The filing shows a derivative exercise/conversion, where 1,310 Restricted Stock Units vested and converted into common stock at $0.00 per share as part of equity compensation.

What happened to Judy D. Olian’s Restricted Stock Units at UNITED THERAPEUTICS (UTHR)?

On July 9, 2026, 1,310 Restricted Stock Units vested and were converted on a one-for-one basis into 1,310 common shares. The reported Restricted Stock Unit balance after this vesting is 0 units.

Do the vested UNITED THERAPEUTICS (UTHR) Restricted Stock Units have an expiration date?

According to the filing footnote, an expiration date is not applicable to these Restricted Stock Units because they do not have an expiration date; instead, they vest and convert into common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/13/2026 - 04:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Olian Judy D.

(Last) (First) (Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING MARYLAND 20910

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/09/2026		M(1)		1,310	A	$0.00(1)	5,555	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.00(1)	07/09/2026		M(1)			1,310	07/09/2026	(2)	Common Stock	1,310	(1)	0.00	D

Explanation of Responses:

1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.

2. Not applicable as restricted stock units do not have an expiration date.

Remarks:

	/s/ John S. Hess, Jr. under Power of Attorney	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)